Obesity prevalence map: England 2024/25
65% of adults in England are overweight or obese — but that national average hides a 24.6-point gap between areas. This map shows the share of adults aged 18+ classified as overweight or obese across all 106 sub-ICB locations, from 54.4% in North Central London ICB - 93C to 79% in Staffordshire and Stoke-on-Trent ICB - 04Y.
Where obesity is highest and lowest
Darker shading marks higher adult overweight and obesity prevalence. The pattern is broadly north-and-coast heavy: the North East, Yorkshire, the West Midlands and parts of the South West run hottest, while large parts of inner and outer London sit lowest.
Does obesity track deprivation?
Partly — but less than the headlines suggest. Across the 75 areas with matched IMD 2019 deprivation scores, the link is positive but modest (correlation r = 0.34). The most-deprived quarter of areas average 69.5% overweight or obese, against 65.2% in the least-deprived quarter — a real gap, but deprivation explains only a fraction of the area-to-area variation.
The clearest exception is London: several of its most income-deprived areas record England's lowest adult overweight rates, pulling the national correlation down. Population age structure is not the driver here — the underlying figures are age-standardised, so differences in how old each area is have already been removed.
NHS obesity-drug prescribing: a postcode lottery
NHS dispensing of obesity medicines (BNF section 4.5) broadly follows prevalence — higher-prevalence ICBs tend to prescribe more (r = 0.46 across 30 ICBs, to 2026-03). But the spread is enormous: Black Country dispenses 16.7 items per 1,000 patients, while Northamptonshire dispenses just 0.6 — a roughly 28-fold difference that prevalence alone cannot explain.
Because this counts NHS prescriptions only, it misses the large and growing volume of privately prescribed weight-loss medication — which is exactly where most people now obtain treatments like tirzepatide and semaglutide. A low NHS prescribing rate does not mean low local demand; it often means people are going private instead.
| Integrated Care Board | Overweight/obese | NHS obesity-drug items / 1,000 |
|---|---|---|
| Black Country | 71.2% | 16.7 |
| South Yorkshire | 71% | 15.9 |
| Staffordshire And Stoke-On-Trent | 69.8% | 14.5 |
| Lincolnshire | 69.1% | 14.2 |
| North East And North Cumbria | 69.9% | 13.5 |
| Coventry And Warwickshire | 66.5% | 13.3 |
| Cheshire And Merseyside | 67.5% | 13.3 |
| Humber And North Yorkshire | 68% | 13.1 |
| Lancashire And South Cumbria | 67.5% | 13 |
| Birmingham And Solihull | 66.1% | 11.8 |
| Greater Manchester | 66.3% | 11.7 |
| Leicester, Leicestershire And Rutland | 65% | 10.8 |
| Herefordshire And Worcestershire | 63.2% | 9.5 |
| Cornwall And The Isles Of Scilly | 69% | 9.3 |
| North East London | 61.2% | 9.1 |
| Derby And Derbyshire | 67.6% | 8.3 |
| West Yorkshire | 66.8% | 7.5 |
| Dorset | 65.5% | 7.4 |
| Kent And Medway | 66.6% | 7.3 |
| Shropshire, Telford And Wrekin | 67% | 7.2 |
| South West London | 56.5% | 7.2 |
| Somerset | 68.4% | 7.1 |
| South East London | 58.3% | 6.2 |
| Devon | 64.3% | 5.9 |
| Bath And North East Somerset, Swindon And Wiltshire | 62.3% | 5.7 |
| Hampshire And Isle Of Wight | 63.9% | 5.1 |
| Gloucestershire | 66.2% | 4.6 |
| Bristol, North Somerset And South Gloucestershire | 61.4% | 4.3 |
| Nottingham And Nottinghamshire | 68.5% | 2.4 |
| Northamptonshire | 68% | 0.6 |
NHS dispensing, BNF section 4.5, items per 1,000 registered patients, 12 months to 2026-03. Source: OpenPrescribing.net. ICBs shown where a population denominator was available.
The affordability gap: where treatment costs the most income
Private weight-loss treatment is priced nationally, but incomes are not. Across UK providers, a typical mid-range maintenance dose of GLP-1 treatment runs roughly £219–£268 a month — on the order of £2,820 a year. Set that against disposable income per head and the burden falls hardest exactly where obesity is highest. In the North East — England's highest-prevalence region at 70.3% — a year of treatment equals 15.3% of per-head disposable income, against just 8.7% in London, the lowest-prevalence region. The same price is a 1.8× heavier load on the places with the greatest need.
| Region | Overweight/obese | Disposable income / head | A year of treatment |
|---|---|---|---|
| North East | 70.3% | £18,388 | 15.3% of income |
| Yorkshire and The Humber | 68.2% | £19,249 | 14.7% of income |
| West Midlands | 67.6% | £19,480 | 14.5% of income |
| North West | 67% | £19,752 | 14.3% of income |
| East Midlands | 67.5% | £19,879 | 14.2% of income |
| South West | 64.7% | £22,612 | 12.5% of income |
| East of England | 65.2% | £23,661 | 11.9% of income |
| South East | 63% | £26,058 | 10.8% of income |
| London | 57.4% | £32,330 | 8.7% of income |
Income: ONS regional gross disposable household income (GDHI) per head, 2022. Treatment cost is a UK category figure based on published pharmacy list prices for a mid-range maintenance dose of GLP-1 weight-loss treatment (median across 33 UK providers, March 2026) — it is not a specific product, brand or provider price, and is shown only to express affordability as a share of income. “A year of treatment” = £2,820 as a percentage of per-head disposable income.
The affordability angle
Private weight-loss treatment is priced nationally — an online provider charges the same whether you live in the highest-prevalence area or the lowest. That means the places with the greatest need are often the least able to fund treatment privately when NHS access is limited. If you are weighing up your options, compare what UK providers actually charge for consultations and monitoring before you commit.
Compare UK weight-loss provider pricing →Every area ranked (106 sub-ICB locations)
Adult overweight and obesity prevalence for 2024/25, highest to lowest, with each area's gap to the 65% England average.
| # | Sub-ICB location | Overweight/obese | vs England |
|---|---|---|---|
| 1 | Staffordshire and Stoke-on-Trent ICB - 04Y | 79% | +14 |
| 2 | North East and North Cumbria ICB - 00P | 77% | +12 |
| 3 | Cheshire and Merseyside ICB - 01J | 74.6% | +9.6 |
| 4 | South Yorkshire ICB - 02P | 74.4% | +9.4 |
| 5 | North East and North Cumbria ICB - 00N | 74.4% | +9.4 |
| 6 | Humber and North Yorkshire ICB - 03K | 74.2% | +9.2 |
| 7 | Greater Manchester ICB - 02H | 73.7% | +8.7 |
| 8 | Staffordshire and Stoke-on-Trent ICB - 05W | 73.6% | +8.6 |
| 9 | North East and North Cumbria ICB - 00L | 73.3% | +8.3 |
| 10 | West Yorkshire ICB - 03R | 73.2% | +8.2 |
| 11 | Cheshire and Merseyside ICB - 01F | 73.1% | +8.1 |
| 12 | Cheshire and Merseyside ICB - 01T | 73% | +8 |
| 13 | South Yorkshire ICB - 03L | 72.5% | +7.5 |
| 14 | Nottingham and Nottinghamshire ICB - 02Q | 71.8% | +6.8 |
| 15 | Cheshire and Merseyside ICB - 12F | 71.8% | +6.8 |
| 16 | South Yorkshire ICB - 02X | 71.5% | +6.5 |
| 17 | Mid and South Essex ICB - 07G | 71.3% | +6.3 |
| 18 | Black Country ICB - D2P2L | 71.2% | +6.2 |
| 19 | North East and North Cumbria ICB - 16C | 70.8% | +5.8 |
| 20 | Mid and South Essex ICB - 99F | 70.7% | +5.7 |
| 21 | Lancashire and South Cumbria ICB - 02G | 70.7% | +5.7 |
| 22 | Lancashire and South Cumbria ICB - 00X | 70.6% | +5.6 |
| 23 | Mid and South Essex ICB - 99E | 70.4% | +5.4 |
| 24 | West Yorkshire ICB - 02T | 70.4% | +5.4 |
| 25 | Humber and North Yorkshire ICB - 03H | 70.2% | +5.2 |
| 26 | Staffordshire and Stoke-on-Trent ICB - 05D | 69.8% | +4.8 |
| 27 | Humber and North Yorkshire ICB - 03F | 69.6% | +4.6 |
| 28 | North East and North Cumbria ICB - 84H | 69.3% | +4.3 |
| 29 | Lancashire and South Cumbria ICB - 01A | 69.1% | +4.1 |
| 30 | Lincolnshire ICB - 71E | 69.1% | +4.1 |
| 31 | Cornwall and The Isles Of Scilly ICB - 11N | 69% | +4 |
| 32 | Greater Manchester ICB - 01Y | 68.8% | +3.8 |
| 33 | Cheshire and Merseyside ICB - 01X | 68.6% | +3.6 |
| 34 | Humber and North Yorkshire ICB - 02Y | 68.5% | +3.5 |
| 35 | Somerset ICB - 11X | 68.4% | +3.4 |
| 36 | Cheshire and Merseyside ICB - 01V | 68.4% | +3.4 |
| 37 | Nottingham and Nottinghamshire ICB - 52R | 68.4% | +3.4 |
| 38 | Lancashire and South Cumbria ICB - 02M | 68.3% | +3.3 |
| 39 | Greater Manchester ICB - 01D | 68.1% | +3.1 |
| 40 | Greater Manchester ICB - 00Y | 68.1% | +3.1 |
| 41 | West Yorkshire ICB - X2C4Y | 68.1% | +3.1 |
| 42 | Northamptonshire ICB - 78H | 68% | +3 |
| 43 | Greater Manchester ICB - 00T | 67.9% | +2.9 |
| 44 | Cheshire and Merseyside ICB - 99A | 67.9% | +2.9 |
| 45 | Greater Manchester ICB - 01G | 67.9% | +2.9 |
| 46 | Leicester, Leicestershire and Rutland ICB - 04V | 67.9% | +2.9 |
| 47 | Bedfordshire, Luton and Milton Keynes ICB - M1J4Y | 67.9% | +2.9 |
| 48 | Lancashire and South Cumbria ICB - 00R | 67.8% | +2.8 |
| 49 | North East and North Cumbria ICB - 13T | 67.8% | +2.8 |
| 50 | Derby and Derbyshire ICB - 15M | 67.6% | +2.6 |
| 51 | North East and North Cumbria ICB - 01H | 67.5% | +2.5 |
| 52 | South Yorkshire ICB - 03N | 67.4% | +2.4 |
| 53 | Staffordshire and Stoke-on-Trent ICB - 05Q | 67.2% | +2.2 |
| 54 | Mid and South Essex ICB - 06Q | 67.1% | +2.1 |
| 55 | Suffolk and North East Essex ICB - 06T | 67.1% | +2.1 |
| 56 | Lancashire and South Cumbria ICB - 00Q | 67% | +2 |
| 57 | Leicester, Leicestershire and Rutland ICB - 03W | 67% | +2 |
| 58 | Shropshire, Telford and Wrekin ICB - M2L0M | 67% | +2 |
| 59 | Humber and North Yorkshire ICB - 03Q | 66.9% | +1.9 |
| 60 | Kent and Medway ICB - 91Q | 66.6% | +1.6 |
| 61 | Coventry and Warwickshire ICB - B2M3M | 66.5% | +1.5 |
| 62 | Gloucestershire ICB - 11M | 66.2% | +1.2 |
| 63 | Staffordshire and Stoke-on-Trent ICB - 05G | 66.1% | +1.1 |
| 64 | Lancashire and South Cumbria ICB - 01E | 66.1% | +1.1 |
| 65 | Birmingham and Solihull ICB - 15E | 66.1% | +1.1 |
| 66 | Suffolk and North East Essex ICB - 07K | 65.9% | +0.9 |
| 67 | Norfolk and Waveney ICB - 26A | 65.6% | +0.6 |
| 68 | Dorset ICB - 11J | 65.5% | +0.5 |
| 69 | Hampshire and Isle Of Wight ICB - 10R | 65.5% | +0.5 |
| 70 | Greater Manchester ICB - 00V | 65.4% | +0.4 |
| 71 | Staffordshire and Stoke-on-Trent ICB - 05V | 65.3% | +0.3 |
| 72 | West Yorkshire ICB - 15F | 65% | 0 |
| 73 | Humber and North Yorkshire ICB - 42D | 64.9% | -0.1 |
| 74 | Suffolk and North East Essex ICB - 06L | 64.8% | -0.2 |
| 75 | Hertfordshire and West Essex ICB - 06K | 64.6% | -0.4 |
| 76 | Hertfordshire and West Essex ICB - 07H | 64.4% | -0.6 |
| 77 | Devon ICB - 15N | 64.3% | -0.7 |
| 78 | West Yorkshire ICB - 36J | 64% | -1 |
| 79 | Cheshire and Merseyside ICB - 27D | 64% | -1 |
| 80 | Hampshire and Isle Of Wight ICB - D9Y0V | 63.7% | -1.3 |
| 81 | Sussex ICB - 97R | 63.3% | -1.7 |
| 82 | Greater Manchester ICB - 02A | 63.2% | -1.8 |
| 83 | Herefordshire and Worcestershire ICB - 18C | 63.2% | -1.8 |
| 84 | Sussex ICB - 70F* | 63.1% | -1.9 |
| 85 | Buckinghamshire, Oxfordshire and Berkshire West ICB - 14Y | 63% | -2 |
| 86 | Bath and North East Somerset, Swindon and Wiltshire ICB - 92G | 62.3% | -2.7 |
| 87 | Frimley ICB - D4U1Y | 62.3% | -2.7 |
| 88 | Leicester, Leicestershire and Rutland ICB - 04C | 61.8% | -3.2 |
| 89 | Greater Manchester ICB - 01W | 61.8% | -3.2 |
| 90 | Lancashire and South Cumbria ICB - 01K | 61.5% | -3.5 |
| 91 | Cheshire and Merseyside ICB - 02E | 61.4% | -3.6 |
| 92 | Bristol, North Somerset and South Gloucestershire ICB - 15C | 61.4% | -3.6 |
| 93 | Hertfordshire and West Essex ICB - 06N | 61.2% | -3.8 |
| 94 | North East London ICB - A3A8R | 61.2% | -3.8 |
| 95 | North East and North Cumbria ICB - 99C | 61.1% | -3.9 |
| 96 | Greater Manchester ICB - 14L | 60.9% | -4.1 |
| 97 | Cambridgeshire and Peterborough ICB - 06H | 60.7% | -4.3 |
| 98 | Buckinghamshire, Oxfordshire and Berkshire West ICB - 15A | 60.3% | -4.7 |
| 99 | Surrey Heartlands ICB - 92A* | 59.4% | -5.6 |
| 100 | Buckinghamshire, Oxfordshire and Berkshire West ICB - 10Q | 59.3% | -5.7 |
| 101 | South East London ICB - 72Q | 58.3% | -6.7 |
| 102 | Mid and South Essex ICB - 99G | 58.2% | -6.8 |
| 103 | South West London ICB - 36L | 56.5% | -8.5 |
| 104 | North West London ICB - W2U3Z | 56% | -9 |
| 105 | Sussex ICB - 09D | 55.2% | -9.8 |
| 106 | North Central London ICB - 93C | 54.4% | -10.6 |
* Surrey Heartlands (92A) and Sussex (70F) sub-ICBs changed boundaries in 2023; the parent-ICB value is shown for continuity.
Methodology & caveats
- Source: OHID Fingertips indicator 93088, “Overweight (including obesity) prevalence in adults”, derived from the Active Lives Adult Survey (Sport England), 2024/25.
- Self-reported: height and weight are self-reported and statistically adjusted by OHID. They still tend to under-count true prevalence relative to the measured Health Survey for England, so read these as a conservative floor.
- Age-standardised: figures are age-standardised, so area age structure has been removed — differences are not an artefact of some areas being older.
- Geography: 106 sub-ICB locations on ONS SICBL July 2022 (ultra-generalised, clipped) boundaries. OHID publishes only a combined (Persons) figure at this level — sex breakdowns and the longer time series exist only at ICB, regional and England level.
- Deprivation: IMD 2019 average scores, matched for 75 of the 106 areas (IMD predates the 2022 boundaries, so some areas are unmatched).
- Prescribing: NHS dispensing of BNF section 4.5 obesity medicines via OpenPrescribing.net, items per 1,000 registered patients, 12 months to 2026-03. Excludes private prescriptions.
Frequently asked questions
What percentage of adults in England are overweight or obese?
In 2024/25, 65% of adults aged 18+ in England were classified as overweight or obese, based on OHID's processing of the Active Lives Adult Survey. Figures use adjusted self-reported height and weight and are age-standardised.
Which area of England has the highest obesity prevalence?
Among the 106 sub-ICB locations, Staffordshire and Stoke-on-Trent ICB - 04Y has the highest adult overweight or obese prevalence at 79%, while North Central London ICB - 93C has the lowest at 54.4% — a 24.6-point spread across England.
Is obesity higher in more deprived areas?
There is a positive but modest link: the most-deprived quarter of areas average 69.5% versus 65.2% in the least-deprived quarter (correlation r = 0.34). Deprivation explains only part of the variation — several deprived inner-London areas record England's lowest adult overweight rates.
Is private weight-loss treatment harder to afford in some regions?
Yes. Private GLP-1 weight-loss treatment is priced nationally — roughly £219–£268 a month — but disposable income varies sharply by region. A year of treatment equals about 15.3% of per-head disposable income in the North East, England's highest-prevalence region, versus 8.7% in London. The cost falls hardest where overweight and obesity are most common. (Cost is an illustrative category figure, not a brand or provider price.)
Is this measured or self-reported data?
It is self-reported height and weight from the Active Lives survey, statistically adjusted by OHID to better align with measured data. Self-reported figures still tend to understate true prevalence compared with the measured Health Survey for England, so treat these as a conservative floor.
Sources & further reading
- OHID Fingertips — Obesity, physical activity and nutrition profile — Adult overweight/obesity prevalence (indicator 93088), Active Lives Adult Survey.
- Sport England — Active Lives Adult Survey — Underlying self-reported height and weight data.
- ONS Open Geography Portal — Sub-ICB Locations (July 2022) — Sub-ICB location boundaries used for the map.
- OpenPrescribing.net — NHS obesity-drug dispensing by ICB.
- ONS — Regional gross disposable household income (GDHI) — Disposable income per head by region, used for the affordability section.
- NHS — Mounjaro and Wegovy eligibility — Who qualifies for NHS-funded weight-loss medication.
Guides & articles
In-depth guides and cost breakdowns from the TreatCompare editorial team.
Why BMI Thresholds Are Lower for South Asian, Chinese & Black UK Patients (2026)
NICE and WHO recommend lower BMI thresholds for South Asian, Chinese, Black African and Caribbean people because cardiometabolic risk rises at lower BMI. Here's what that means for Mounjaro, Wegovy and NHS weight management eligibility.
Lower-Cost Weight Loss Injections UK 2026: NHS Access, Service Fees and Provider Checks
Lower-cost weight loss injections UK guide: how to compare private consultation service fees, NHS eligibility, follow-up costs and provider safety checks without public prescription-medicine price tables.
How to Get Mounjaro in the UK: Patient Information (2026)
Patient information about UK NHS and private routes for Mounjaro (tirzepatide). Not an advertisement and not medical advice.
Who Should Not Take Mounjaro or Wegovy? A GP's Guide
A UK GP's guide to who should not take Mounjaro (tirzepatide) or Wegovy (semaglutide), who needs extra caution, and the red-flag symptoms that need urgent medical help. Patient information, not medical advice.
Mounjaro Price UK 2026: Cost Questions, NHS Access and Provider Checks
Mounjaro price UK guide: why prescription-medicine prices are not displayed, what private service fees to ask about, NHS access and GPhC provider checks.
Wegovy Price UK 2026: Cost Questions, NHS Access and Provider Checks
Wegovy price UK guide: why prescription-medicine prices are not displayed, what private service fees to ask about, NHS access and provider checks.